Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: An in vitro study

Journal of Urology

Volumn 173, Issue 4, 2005, Pages 1375-1380

  Van Der Heijden, Antoine G ^a   Verhaegh, Gerald ^a   Jansen, Cornelius F J ^a   Schalken, Jack A ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder; Carcinoma, transitional cell; Cell proliferation; Drug therapy; Fever

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIRUBICIN; GEMCITABINE; MITOMYCIN C;

ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; INCUBATOR; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

EID: 15044358944     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000146274.85012.e1     Document Type: Article

References (20)

1. Coley, W. B.: The treatment of malignant tumors by repeated inoculations of erysipelas with a report of 10 original cases. Am J Med Sci, p. 488, 1891
2. Colombo, R., Da Pozzo, L. F., Salonia, A., Rigatti, P., Leib, Z., Baniel, J. et al: Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol, 21: 4270, 2003
3. Gofrit, O. N., Shapiro, A., Pode, D., Sidi, A., Nativ, O., Leib, Z. et al: Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology, 63: 466, 2004
4. Matzkin, H., Rangel, M. C. and Soloway, M. S.: In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines. J Urol, 147: 1671, 1992
5. van der Heijden, A. G., Jansen, C. F., Verhaegh, G., O'donnell, M. A., Schalken, J. A. and Witjes, J. A.: The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol, 46: 670, 2004
6. Tomasz, M., Chowdary, D., Lipman, R., Shimotakahara, S., Veiro, D., Walker, V. et al: Reaction of DNA with chemically or enzymatically activated mitomycin C: isolation and structure of the major covalent adduct. Proc Natl Acad Sci USA, 83: 6702, 1986
7. Collard, J., Matthew, A. M., Double, J. A. and Bibby, M. C.: EO9: relationship between DT-diaphorase levels and response in vitro and in vivo. Br J Cancer, 71: 1199, 1995
8. Booth, C., Harnden, P., Trejdosiewicz, L. K., Scriven, S., Selby, P. J. and Southgate, J.: Stromal and vascular invasion in an human in vitro bladder cancer model. Lab Invest, 76: 843, 1997
9. Davies, G., Jiang, W. G. and Mason, M. D.: Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion. Anticancer Res, 19: 547, 1999
10. Elliott, A. Y., Bronson, D. L., Cervenka, J., Stein, N. and Fraley, E. E.: Properties of cell lines established from transitional cell cancers of the human urinary tract. Cancer Res, 37: 1279, 1977
11. Cavaliere, R., Ciocatto, E. C., Giovanella, B. C., Heidelberger, C., Johnson, R. O., Margottini, M. et al: Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer, 20: 1351, 1967
12. Hahn, G. M. and Li, G. C.: Interactions of hyperthermia and drugs: treatments and probes. Natl Cancer Inst Monogr, 61: 317, 1982
13. Colombo, R., Da Pozzo, L. F., Lev, A., Freschi, M., Galus, G. and Rigatti, P.: Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol, 155: 1227, 1996
14. Colombo, R., Brausi, M., Da Pozzo, L., Salonia, A., Montorsi, F., Scattoni, V. et al: Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. A pilot study on marker lesion. Eur Urol, 39: 95, 2001
15. Loadman, P. M., Bibby, M. C. and Phillips, R. M.: Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9. Br J Pharmacol, 137: 701, 2002
16. McLeod, H. L., Graham, M. A., Aamdal, S., Setanoians, A., Groot, Y. and Lund, B.: Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9. EORTC Early Clinical Trials Group. Eur J Cancer, 32A: 1518, 1996
17. Van Bree, C., Beumer, C., Rodermond, H. M., Haven, J. and Bakker, P. J.: Effectiveness of 2′,2′difluorodeoxycytidine (Gemcitabine) combined with hyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo. Int J Hyperthermia, 15: 549, 1999
18. Caelles, C., Helmberg, A. and Karin, M.: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370: 220, 1994
19. Hainaut, P., Butcher, S. and Milner, J.: Temperature sensitivity for conformation is an intrinsic property of wild-type p53. Br J Cancer, 71: 227, 1995
20. Guan, J., Stavridi, E., Leeper, D. B. and Iliakis, G.: Effects of hyperthermia on p53 protein expression and activity. J Cell Physiol, 190: 365, 2002